Three Years Survival Outcome And Continued Cemiplimab (CEMI) Beyond Progression With The Addition Of Chemotherapy (Chemo) For Patients (Pts) With Advanced Non-Small Cell Lung Cancer (NSCLC): The EMPOWER-Lung 1 Trial

No Thumbnail Available

Files

127.pdf (103.29 KB)

Date

2022

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

https://reader.elsevier.com/reader/sd/pii/S0923753422039345?token=71A2014D03917840BAA6B9F5FF6D27514DC3A1A11C5ACA71B082418092AA82EE053976F23B46425060D9A4E2069A7D6B&originRegion=eu-west-1&originCreation=20230102073637
 http://hdl.handle.net/11727/8488

Collections

Tıp Fakültesi / Faculty of Medicine
Wos Açık Erişimli Yayınlar
Wos İndeksli Yayınlar Koleksiyonu

Endorsement

Review

Supplemented By

Referenced By